TMO - Thermo Fisher Scientific Inc

NYSE * Health Care * Life Sciences Tools & Services

$521.11

+$0.99 (+0.19%)

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

TMO Key Statistics

Market Cap

$195.79B

P/E Ratio

29.41

P/B Ratio

3.66

EPS

$17.72

Dividend Yield

0.00%

Revenue Growth

+0.1%

Profit Margin

0.2%

Employees

125,000

How TMO Compares to Peers

TMO trades at a premium valuation vs peers (highest P/E)
TMO has the highest profit margins in Life Sciences Tools & Services
TMO is the smallest among peers, which may offer higher growth potential

P/E Rank

#2

of 2

Margin Rank

#1

of 2

Growth Rank

#2

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
TMO29.40%-
AMZN29.30%vs AMZN

Thermo Fisher Scientific Inc Company Information

Headquarters
Massachusetts; U.S.A
Website
www.thermofisher.com
Sector
Health Care
Industry
Life Sciences Tools & Services
Data Updated:
Ready to invest in TMO?

Commission-free trading available. Affiliate links.

TMO Lician Score

10% confidence
5.0/10
Neutral

TMO has a Lician Score of 5/10 (Average). The stock shows average characteristics across all dimensions.

value

5.0

growth

5.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates TMOacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

TMO Financial Snowflake

5-axis analysis across key investment dimensions

5.0/10

Neutral

35810Value5.0Growth5.0Quality5.0Momentum5.0Safety5.05.0/10
5.0

Value

5.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for TMO